0001562180-21-002740.txt : 20210407
0001562180-21-002740.hdr.sgml : 20210407
20210407164349
ACCESSION NUMBER: 0001562180-21-002740
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210405
FILED AS OF DATE: 20210407
DATE AS OF CHANGE: 20210407
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Obenshain Andrew
CENTRAL INDEX KEY: 0001839697
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35966
FILM NUMBER: 21812622
MAIL ADDRESS:
STREET 1: 491 CHESTNUT STREET
CITY: WABAN
STATE: MA
ZIP: 02468
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: bluebird bio, Inc.
CENTRAL INDEX KEY: 0001293971
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 339-499-9300
MAIL ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc
DATE OF NAME CHANGE: 20040616
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-04-05
false
0001293971
bluebird bio, Inc.
BLUE
0001839697
Obenshain Andrew
C/O BLUEBIRD BIO, INC.
60 BINNEY STREET
CAMBRIDGE
MA
02142
false
true
false
false
President of SGD
Common Stock
2021-04-05
4
S
false
29.00
30.2051
D
40137.00
D
Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
The range in prices for the transaction reported on this line was $30.05 to $30.52. The average weighted price was $30.2051. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Helen C. Fu, Attorney-in-Fact
2021-04-07
EX-24
2
aobenshainpoa.txt
POA
LIMITED POWER OF ATTORNEY
The undersigned hereby constitutes and appoints each of Jason F.
Cole, Helen Fu and Katy Burnett, and each of them individually, and
with full power of substitution, the undersigned's true and lawful
attorney-in-fact to:
(1) Complete and execute for and on behalf of the undersigned,
in the undersigned's capacity as an officer, director and/or ten
percent (10%) shareholder of bluebird bio, Inc., a Delaware
corporation (the "Company") any and all instruments, certificates and
documents required to be executed on behalf of the undersigned as an
individual or on behalf of the undersigned's company or partnership,
as the case may be, pursuant to Section 13 and Section 16 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act") or
the rules and regulations thereunder;
(2) Do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such instruments, certificates or documents required to
be filed pursuant to Sections 13 and 16 of the Exchange Act or the
rules or regulations thereunder and timely file such forms with the
United States Securities and Exchange Commission and any stock
exchange or similar authority; and
(3) Take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorney-in-fact,
may be of benefit to, in the best interest of, or legally required
by, the undersigned, it being understood that the documents executed
by any such attorney-in-fact on behalf of the undersigned pursuant to
this Power of Attorney shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact,
acting singly, full power and authority to do and perform any and
every act which is necessary, proper or desirable to be done in the
exercise of any of the rights and powers herein granted, as fully to
all intents and purposes as the undersigned might or could do if
personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that any such attorney-in-fact,
or any such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Power of Attorney
and the rights and powers herein granted.
The undersigned acknowledges that each of the foregoing
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of
the undersigned's responsibilities to comply with Section 13 or
Section 16 of the Exchange Act or the rules or regulations
thereunder. The undersigned hereby agrees to indemnify each
attorney-in-fact and the Company from and against any demand, damage,
loss, cost or expense arising from any false or misleading
information provided by the undersigned to such attorney-in fact.
This Power of Attorney shall remain in full force and effect
until the undersigned is no longer required to file any instruments,
certificates and documents pursuant to Section 13 and 16 of the
Exchange Act or the rules or regulations thereunder with respect to
the undersigned's holdings of and transactions in securities issued
by the Company, unless earlier revoked by the undersigned in a signed
writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of January 11, 2021.
/s/ Andrew Obenshain
Andrew Obenshain